ACE Report Cover
Comparing Autologous Blood, Corticosteroid, & A Combined Injection of Both For Lateral Epicondylitis
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SHOULDER & ELBOW
Comparing Autologous Blood, Corticosteroid, & A Combined Injection of Both For Lateral Epicondylitis .

Comparing autologous blood, corticosteroid, and a combined injection of both for treating lateral epicondylitis: a randomized clinical trial.

J Orthop Traumatol . 2024 Jul 4;25(1):34.
Contributing Authors

A Cakar OD Gozlu

One hundred and twenty patients with lateral epicondylitis were randomized to receive autologous blood injections (AB; n=40), corticosteroid injections (CS; n=40), or a combined injection of both (AB+CS; n=40). The primary outcome of interest was the improvement in the patient-rated tennis elbow evaluation (PRTEE) score. Secondary outcomes included changes in hand grip strength (HGS), functional improvement, and recurrence rates. Outcomes were assessed at baseline, 15, 30, and 90 days post-treatment. Overall, the combined AB+CS group achieved the most significant and sustained improvement in PRTEE and HGS scores, with 97.4% achieving clinically significant improvement compared to 85% and 55% in the AB and CS groups, respectively. The results suggest that a combined AB+CS injection is more effective for rapid and sustained recovery than either treatment alone.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Comparing Autologous Blood, Corticosteroid, & A Combined Injection of Both For Lateral Epicondylitis. ACE Report. 2025;307(1):102. Available from: https://myorthoevidence.com/AceReport/Show/comparing-autologous-blood-corticosteroid-a-combined-injection-of-both-for-lateral-epicondylitis

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report